230 related articles for article (PubMed ID: 15557430)
1. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy.
Maugeri A; Meire F; Hoyng CB; Vink C; Van Regemorter N; Karan G; Yang Z; Cremers FP; Zhang K
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4263-7. PubMed ID: 15557430
[TBL] [Abstract][Full Text] [Related]
2. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability.
Karan G; Yang Z; Zhang K
Mol Vis; 2004 Mar; 10():248-53. PubMed ID: 15073583
[TBL] [Abstract][Full Text] [Related]
3. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.
Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R
Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284
[TBL] [Abstract][Full Text] [Related]
4. Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants.
Karan G; Yang Z; Howes K; Zhao Y; Chen Y; Cameron DJ; Lin Y; Pearson E; Zhang K
Mol Vis; 2005 Aug; 11():657-64. PubMed ID: 16145543
[TBL] [Abstract][Full Text] [Related]
5. Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene.
Bernstein PS; Tammur J; Singh N; Hutchinson A; Dixon M; Pappas CM; Zabriskie NA; Zhang K; Petrukhin K; Leppert M; Allikmets R
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3331-6. PubMed ID: 11726641
[TBL] [Abstract][Full Text] [Related]
6. Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes.
Vasireddy V; Vijayasarathy C; Huang J; Wang XF; Jablonski MM; Petty HR; Sieving PA; Ayyagari R
Mol Vis; 2005 Aug; 11():665-76. PubMed ID: 16163264
[TBL] [Abstract][Full Text] [Related]
7. A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family.
Edwards AO; Donoso LA; Ritter R
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2652-63. PubMed ID: 11581213
[TBL] [Abstract][Full Text] [Related]
8. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.
Zhang K; Kniazeva M; Han M; Li W; Yu Z; Yang Z; Li Y; Metzker ML; Allikmets R; Zack DJ; Kakuk LE; Lagali PS; Wong PW; MacDonald IM; Sieving PA; Figueroa DJ; Austin CP; Gould RJ; Ayyagari R; Petrukhin K
Nat Genet; 2001 Jan; 27(1):89-93. PubMed ID: 11138005
[TBL] [Abstract][Full Text] [Related]
9. Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4.
Grayson C; Molday RS
J Biol Chem; 2005 Sep; 280(37):32521-30. PubMed ID: 16036915
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant macular atrophy at 6q14 excludes CORD7 and MCDR1/PBCRA loci.
Griesinger IB; Sieving PA; Ayyagari R
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):248-55. PubMed ID: 10634627
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of eukaryotic cell expression of wild-type and Pro370Leu mutation type myocilin gene].
Wang JW; Sun HM; Ji J; Li XR; Zheng JQ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):700-4. PubMed ID: 16681932
[TBL] [Abstract][Full Text] [Related]
12. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
[TBL] [Abstract][Full Text] [Related]
13. Localization of lens intrinsic membrane protein MP19 and mutant protein MP19(To3) using fluorescent expression vectors.
Chen T; Li X; Yang Y; Church RL
Mol Vis; 2002 Oct; 8():372-88. PubMed ID: 12379840
[TBL] [Abstract][Full Text] [Related]
14. Does lens intrinsic membrane protein MP19 contain a membrane-targeting signal?
Chen T; Li X; Yang Y; Erdene AG; Church RL
Mol Vis; 2003 Dec; 9():735-46. PubMed ID: 14735063
[TBL] [Abstract][Full Text] [Related]
15. Autosomal dominant Stargardt-like macular dystrophy: identification of a new family with a mutation in the ELOVL4 gene.
Vrabec TR; Tantri A; Edwards A; Frost A; Donoso LA
Am J Ophthalmol; 2003 Sep; 136(3):542-5. PubMed ID: 12967813
[TBL] [Abstract][Full Text] [Related]
16. Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca2+ channels.
Jeng CJ; Sun MC; Chen YW; Tang CY
J Cell Physiol; 2008 Feb; 214(2):422-33. PubMed ID: 17654512
[TBL] [Abstract][Full Text] [Related]
17. Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration.
Sommer JR; Estrada JL; Collins EB; Bedell M; Alexander CA; Yang Z; Hughes G; Mir B; Gilger BC; Grob S; Wei X; Piedrahita JA; Shaw PX; Petters RM; Zhang K
Br J Ophthalmol; 2011 Dec; 95(12):1749-54. PubMed ID: 21873315
[TBL] [Abstract][Full Text] [Related]
18. Dominant Stargardt Macular Dystrophy (STGD3) and ELOVL4.
Logan S; Anderson RE
Adv Exp Med Biol; 2014; 801():447-53. PubMed ID: 24664730
[TBL] [Abstract][Full Text] [Related]
19. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
[TBL] [Abstract][Full Text] [Related]
20. Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation.
Hubbard AF; Askew EW; Singh N; Leppert M; Bernstein PS
Arch Ophthalmol; 2006 Feb; 124(2):257-63. PubMed ID: 16476896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
